Dermaxon
  • Home
  • About Us
    • Contact
  • News
  • Science
  • Our Technologies
    • The human brain
    • Skin
    • Pain
  • Pipeline
Select Page
DermaXon Partners with New York Based AI company VantAI For Two Drug Development Programs

DermaXon Partners with New York Based AI company VantAI For Two Drug Development Programs

DermaXon announces its partnership with VantAI, a Roivant Biosciences Vant company, for the rapid acceleration of two of its drug development programs. VantAI leads the computational drug discovery space with technology at the bleeding edge of machine learning and...
DermaXon will be presenting at BIO 2020,  NIH Innovation Zone June 8 -12,  2020

DermaXon will be presenting at BIO 2020, NIH Innovation Zone June 8 -12, 2020

  • Facebook
  • RSS

Copyright, Dermaxon. All rights reserved.